22 septiembre 2015
In a preliminary 10-week randomized trial, patients with probable Alzheimer’s disease who received the combination medication dextromethorphan-quinidine demonstrated less occurrences and severity of agitation, compared to patients who received placebo, according to a study.
http://www.sciencedaily.com/releases/2015/09/150922114725.htm
